1. Home
  2. Companies
  3. TRI
  4. Announcements

Trivarx (ASX:TRI)

ASX announcement history & article coverage

5
Total announcements
(in last 3 months)
3
With article
2
No article
Article coverage
60%
Transparent by design. Announcments by Trivarx (ASX:TRI) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.

25 June 2026 · 09:19 am AEST ASX Filing
Investor Presentation - Stabl-Im program
Company Presentation

26 May 2026 · 02:06 pm AEST ASX Filing
Change of Registered Office Address
Details of Company AddressDetails of Registered office address
22 May 2026 · 09:36 am AEST ⚡ Price SensitiveMaterial ASX Filing
CRO Engaged to Advance Stabl-Im Phase 1 Trial
TrivarX engages CRO Beyond Drug Development to progress Stabl-Im Phase 1 safety trial
Progress Report
70
TrivarX Engages CRO Beyond to Advance Stabl-Im Phase 1 Trial Healthcare Wrap - Week 21 (18 May -> 22 May) 2026 Wrap

30 Apr 2026 · 09:38 am AEST ⚡ Price SensitiveMaterial ASX Filing
March 2026 Quarterly Activities Report and Appendix 4C
TrivarX advances Stabl-Im to Phase 1 trials, appoints new CEO, maintains strong cash position
Commitments Test Entity - Third Quarter Activity ReportCommitments Test Entity - Third Quarter Cashflow Report
80
TrivarX Advances Stabl-Im Brain Imaging Toward Phase 1 Trials with New CEO Appointment Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026 Wrap
29 Apr 2026 · 08:29 am AEST ⚡ Price SensitiveMaterial ASX Filing
Dr Danielle Meyrick appointed as CEO
TrivarX appoints Dr Danielle Meyrick as CEO to advance Stabl-Im brain cancer imaging platform into clinical trials
CEO/Managing Director - Appointment Resignation
85
TrivarX Names Dr Danielle Meyrick CEO to Lead Stabl-Im Brain Cancer Imaging Trials Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026 Wrap